Opioid Resource Center
News
Orally dissolving buprenorphine tied to severe tooth decay, FDA warns
Since buprenorphine was approved, the FDA has identified 305 cases of dental problems associated with orally dissolving buprenorphine.
From the Journals
Opioid agonist therapy guards against self-harm, suicide
These results highlight the importance of a ‘transition’ period when stopping OAT, said study investigator Dr. Prianka Padmanathan.
From the Journals
Short-acting opioids needed for withdrawal in U.S. hospitals, say experts
The short-acting drugs can complement methadone and buprenorphine to help patients get faster relief and help patients stay in the hospital to...
News
U.S. overdose deaths hit an all-time high
Fentanyl and methamphetamine are contributing to rising numbers of fatalities, federal officials say.
Conference Coverage
Warn patients about illicit drugs doctored with fentanyl
Most patients with drug use disorders are testing positive for fentanyl at his center, said Dr. Edwin A. Salsitz, of Mount Sinai Beth Israel.
From the Journals
Good news, bad news for buprenorphine in opioid use disorder
The findings “underscore the need to pursue actions that expand access to buprenorphine-based OUD treatment,” said Dr. Beth Han and associates.
Feature
Opioid prescribing mapped: Alabama highest, New York lowest
The Medicare Part D opioid prescribing rate dropped in all 50 states from 2014 to 2019, but disparities remain.
From the Journals
Opioid overdoses tied to lasting cognitive impairment
One study in the review found that about 39% of people seeking buprenorphine treatment suffered from neurocognitive impairment.
Conference Coverage
Growing proportion of cardiac arrests in U.S. considered opioid related
Due to a steep rise, opioid-associated cardiac arrests have become a major public health issue.
News from the FDA/CDC
EDs saw more benzodiazepine overdoses, but fewer patients overall, in 2020
Fentanyl became increasingly involved in benzodiazepine overdose deaths through the first half of the year.
From the Journals
Opioid prescribing laws having an impact
The number of days an opioid was prescribed for each Medicare beneficiary decreased by 11.6 days in 2018 in states that imposed duration limits....